New applications of cancer immunotherapy.
Agarwala
Sanjiv S
SS
Melanoma Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213-2582, USA.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006632:Histamine / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016233:Immunotherapy, Active; D016898:Interferon-alpha / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology; D009369:Neoplasms / Q000628:therapy
D000276:Adjuvants, Immunologic; D007155:Immunologic Factors; D016898:Interferon-alpha; D007376:Interleukin-2; D006632:Histamine